In plain language
MGF (mechano growth factor) is a splice variant of IGF-1 produced by muscle in response to mechanical stress, studied for its role in activating muscle repair cells. Almost all data comes from cell and animal research, with no human trials of synthetic MGF. What we know is preliminary and does not establish benefit or safety in people.
What it is explored for
MGF is a fascinating natural splice variant of IGF-1 that muscle produces in response to mechanical stress, studied for its role in switching on the cells that repair and rebuild muscle. The biology is genuinely intriguing, but it is important to be honest that the data are preliminary and entirely preclinical, with no human trials of synthetic MGF. Here is where it is being explored.
- Muscle repair and recovery research
- Satellite (stem) cell activation studies
- Local muscle growth signaling
- Response to mechanical loading
- Preclinical growth-factor research
These are areas of active interest and reported use, not proven outcomes. This peptide carries a preliminary evidence rating, see the evidence summary below for how strong the science actually is.
How it works
MGF is a splice variant of IGF-1 expressed by muscle after mechanical loading or damage, studied for its role in the early phase of muscle repair.
- Satellite cell activation. In cell and animal studies it is associated with activating muscle stem (satellite) cells that support repair and growth.
- Distinct from systemic IGF-1. Its unique C-terminal peptide is thought to act locally and earlier than the mature IGF-1 produced systemically.
- Short-acting in research. The native peptide is rapidly degraded, which is why pegylated versions (PEG-MGF) were developed.
All of these observations come from in-vitro and animal studies. There are no human trials of synthetic MGF.
Evidence summary
Evidence for MGF is preliminary. Laboratory and animal studies outline a plausible role in muscle repair, but there are no human trials of administered synthetic MGF, and its rapid breakdown raises questions about whether injected forms reach meaningful activity. Benefit and safety in people are unknown.
Reported safety & side effects
Because there are no human trials, the safety of synthetic MGF in people is unknown. Theoretical concerns relate to growth-signaling peptides and tissue overgrowth.
Frequently asked
Is MGF FDA-approved?
No. MGF is not approved by the FDA for any use. It is sold as a research chemical and is not an approved medicine.
Is there any human evidence for MGF?
No. The evidence is limited to cell and animal studies. There are no published human trials of synthetic MGF, so its effects and safety in people are unknown.
Why was PEG-MGF developed?
Native MGF is broken down very quickly in the body. PEG-MGF attaches a polyethylene glycol chain intended to slow that breakdown and extend activity, though it too lacks human trial evidence.